Aqualung Therapeutics' Phase 2a lung fibrosis study approved by US FDA

Faron launches BLAZE trial with Institute of Cancer Research to address immunotherapy resistance

GSK agrees US pricing framework to expand access to respiratory medicines

Century Health partnerss with Tessel Biosciences to advance early drug development in COPD

Sanofi's efdoralprin alfa receives EU orphan designation for AATD-related emphysema

Hikma launches TYZAVAN in US

PureTech clears key FDA milestone for Phase 3 development of deupirfenidone

DELFI Diagnostics presents preliminary data showing potential for blood-based lung cancer detection in non-smoking population

Orano Med and Roche advance pretargeted radioimmunotherapy into clinical phase

bioMérieux launches equine endocrinology tests to expand point-of-care diagnostics

Sanofi completes acquisition of Vicebio to expand respiratory vaccines portfolio

Neola Medical secures US patent for disposable lung monitoring probes

Spinogenix reports approval of 'tazbentetol' as non-proprietary name for SPG302

Polarean expands XENOVIEW 3T Coil access with Philips compatibility

Immedica gets UAE approval for Zepzelca maintenance treatment